Xin Wang | Epilepsy and neurophysiological research | Best Researcher Award

Posted on by ScienceFather

Dr. Xin Wang | Epilepsy and neurophysiological research | Best Researcher Award

Associate Professor at The First Affiliated Hospital of Wenzhou , China

Dr. Xinshi Wang, M.D., Ph.D. is a Chief Physician, Associate Professor, and Doctoral Supervisor at the Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University. He specializes in epilepsy and cognitive disorders, focusing on molecular mechanisms and therapeutic interventions. Dr. Wang earned his Ph.D. in Neurology from Chongqing Medical University and completed international training as a Visiting Scholar at Monash University & Royal Melbourne Hospital Epilepsy Center. He serves as a Committee Member of the China Anti-Epilepsy Association and Deputy Chair of the Zhejiang Neurology Association Youth Committee. ✨📚

Publication Profile

Scopus

Academic Background

Dr. Xinshi Wang pursued his Ph.D. in Neurology (2013–2017) at Chongqing Medical University, specializing in epilepsy and cognitive disorders 🧠. He obtained his M.Sc. in Neurology (2005–2008) from Wenzhou Medical University, further deepening his expertise in neurological research 🏥. His journey in medicine began with a B.Sc. in Clinical Medicine (1998–2003) at Wenzhou Medical University, where he built a strong foundation in clinical practice and patient care 🏨. With a commitment to advancing neurology, Dr. Wang integrates academic excellence with clinical innovation, contributing significantly to the field of neuroscience. 📚🔬

Professional Background

Dr. Xinshi Wang specializes in clinical and translational research in epilepsy and cognitive disorders, focusing on molecular mechanisms and therapeutic interventions 🔬💊. His dedication to advancing neurology led him to a Visiting Scholar position (Oct 2018 – Oct 2019) at Monash University Central Clinical School & Royal Melbourne Hospital Epilepsy Center, Australia 🌍🏥. This prestigious training, funded by the China Scholarship Council, allowed him to collaborate with global experts, enhancing his expertise in epilepsy research and innovative treatment strategies. His work continues to bridge the gap between laboratory discoveries and clinical applications for neurological disorders. 📚⚕️

🧠 Research Focus

Dr. Xinshi Wang’s research focuses on epilepsy, cognitive disorders, and stroke-related complications, with an emphasis on molecular mechanisms and therapeutic interventions 🧬💊. His studies explore anti-epileptic treatments, oxidative stress, NMDAR deactivation, and biomarkers of cognitive decline 🧪🧠. He has contributed to radiomics-based prediction models, stroke-associated pneumonia, and post-stroke epilepsy 📊🏥. His work also examines amyloid-β and tau pathology in neurodegeneration, advancing precision medicine in neurology. Through clinical and translational research, Dr. Wang aims to improve diagnostic tools and therapeutic strategies for epileptic disorders and cerebrovascular diseases. 🚑📚

Publication Top Notes

1️⃣ An automatic deep-learning approach for the prediction of post-stroke epilepsy after an initial intracerebral hemorrhage based on non-contrast computed tomography imaging 🧠🤖
Year: 2025 | Quantitative Imaging in Medicine and Surgery

2️⃣ Development and internal validation of a prognostic model for predicting tonic-clonic seizures during pregnancy in women with epilepsy 🤰⚡
Year: 2024 | BMC Pregnancy and Childbirth

3️⃣ Development and validation of radiology-clinical statistical and machine learning model for stroke-associated pneumonia after first intracerebral haemorrhage 🏥📊
Year: 2024 | Cited by: 1 | BMC Pulmonary Medicine

4️⃣ NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer’s disease via ATF4-dependent mitochondrial UPR 🧬🧠
Year: 2024 | Cell Death and Disease

Conclusion

Dr. Xinshi Wang is an exceptional candidate for the Best Researcher Award due to his profound contributions to neurology, epilepsy, and cognitive disorders 🧠. With high-impact publications in prestigious journals like Phytomedicine and CNS Neurosci Ther, he has significantly advanced research in neurodegenerative diseases. His work is backed by competitive research funding from NSFC and Zhejiang Natural Science Foundation 💰. As a leader in neurology associations, an editorial board member, and a global collaborator through his Monash University scholarship, Dr. Wang exemplifies excellence in clinical and translational research, making him a top contender for this prestigious award

Yonggeun Hong | Neurophysiology | Excellence in Research

Posted on by ScienceFather

Dr. Yonggeun Hong | Neurophysiology | Excellence in Research

Dr. Yonggeun Hong, Inje University, South Korea

👨‍🔬 Dr. Yonggeun Hong is a distinguished Professor and Director at Inje University, specializing in Biological Clock & Ageing Control. With a Ph.D. in Biochemistry and extensive global research experience, including at Harvard Medical School, he has led groundbreaking studies in areas like neuroscience and cardiovascular health. As Director of Research Centers, including RCAR and BPRC, he’s at the forefront of innovative aging research. His recent work focuses on quantifying neuronal cell-released hydrogen peroxide, employing advanced techniques like 3D mesoporous copper-enriched prussian blue microcubes. Dr. Hong’s contributions significantly advance our understanding of cellular mechanisms in aging and disease.

Publication profile:

Scopus

Google Scholar

Education and Training:

🎓 Dr. Yonggeun Hong embarked on his academic journey at Gyeongsang National University in Jinju, Korea, where he earned his Bachelor of Science in Veterinary Medicine (D.V.M.) from 1988 to 1995. His passion for understanding biological mechanisms led him to pursue further studies, culminating in a Master of Science in Veterinary Physiology from 1995 to 1997, under the guidance of Dr. Joo-Heon Kim. This foundational education laid the groundwork for his subsequent endeavors.Driven by a desire to delve deeper into biochemical intricacies, Dr. Hong pursued a Ph.D. in Biochemistry from 1997 to 2001, with Dr. Yunbae Pak serving as his supervisor at Gyeongsang National University. This phase of his education equipped him with advanced research skills and a comprehensive understanding of cellular processes.Throughout his academic journey, Dr. Hong demonstrated a relentless pursuit of knowledge and a commitment to academic excellence. His diverse educational background in veterinary medicine, physiology, and biochemistry has uniquely positioned him as a multidisciplinary scholar, poised to make significant contributions to the field.

Professional Experiences:

👨‍🔬 Dr. Yonggeun Hong’s illustrious career spans various prestigious roles, reflecting his expertise and leadership in the field of biomedical research. Commencing as a Post-doctoral Research Scholar at the University of Iowa and later at the University of Texas Southwestern Medical Center, he honed his skills in Internal Medicine-Cardiology under the mentorship of Dr. Joseph A. Hill from 2001 to 2004. This foundational experience laid the groundwork for his subsequent endeavors.Transitioning into academia, Dr. Hong joined Inje University in Gimhae, Korea, where he has held multiple pivotal roles. As a Professor since 2004, he leads the Biological Clock & Ageing Control Lab within the Department of Physical Therapy & Rehabilitation, contributing significantly to both education and research. His commitment to advancing knowledge led to directorial positions at key research centers, including the Biohealth Products Research Center (BPRC) from 2014 to 2019 and the u-Healthcare & Anti-aging Research Center (u-HARC) from 2013 to 2015.His international collaborations further enriched his experience, evident during his tenure as a Research Associate at Harvard Medical School-Beth Israel Deaconess Medical Center from 2011 to 2013, under the supervision of Dr. Wenyi Wei, and as a Visiting Research Scholar from 2019 to 2021 in Internal Medicine-Onc/Hem. Presently, as Director of the Research Center for Aged-life Redesign (RCAR) at Inje University, Dr. Hong continues to spearhead innovative research initiatives aimed at understanding and addressing the complexities of aging.

Research Focus:

🔬 Dr. Yonggeun Hong’s research focus revolves around elucidating the intricate mechanisms underlying aging, neurodegenerative diseases, and cancer therapeutics. With a particular emphasis on autophagy, apoptosis, and senescence, his work explores the interplay of cellular processes in conditions such as colorectal cancer and spinal cord injury. Through innovative studies on melatonin treatment, exercise-based neurorehabilitative therapy, and the modulation of insulin/IGF signaling, he aims to uncover novel therapeutic strategies for enhancing neural reconstruction and functional recovery. Dr. Hong’s multifaceted investigations integrate molecular, cellular, and translational approaches to advance our understanding and treatment of age-related disorders and neurological conditions. 🧠🔬

Publication Top Notes:

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1– Cited by 10285, 2021 📑
  2. Therapeutic implications for overcoming radiation resistance in cancer therapy – Cited by 220, 2015 🎯
  3. Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells – Cited by 138, 2014 🌿
  4. The effects of smartphone use on upper extremity muscle activity and pain threshold – Cited by 137, 2015 📱
  5. Differential gene expression patterns in porcine nuclear transfer embryos reconstructed with fetal fibroblasts and mesenchymal stem cells – Cited by 123, 2007 🐖
  6. Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model – Cited by 115, 2018 🧠
  7. Implication of mouse Vps26b–Vps29–Vps35 retromer complex in sortilin trafficking – Cited by 73, 2010 🐭
  8. Molecular and functional interaction of the myokine irisin with physical exercise and Alzheimer’s disease– Cited by 71, 2018 💪
  9. Melatonin plus exercise‐based neurorehabilitative therapy for spinal cord injury– Cited by 69, 2010 🌙
  10. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: a systematic review and meta-analysis of randomized … – Cited by 57, 2021 🧠